NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocolsLinda Zuurbier, Jules P.P. Meijerink, Irene Homminga et al.|Leukemia|2010Cited by 141
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistanceJordy C.G. van der Zwet, Jules P.P. Meijerink, Maarten Altelaar et al.|Leukemia|2021Cited by 48
The Cryptic Chromosomal Deletion, del(11)(p12p13), as a New Activation Mechanism of LMO2 in Pediatric T-Cell Acute Lymphoblastic Leukemia.Pieter Van Vlierberghe, Rob Pieters, Martine van Grotel et al.|Blood|2006Cited by 13
The Central Role of MAPK-ERK Signaling in IL7-Dependent and IL7-Independent Steroid Resistance Reveals a Broad Application of MEK-Inhibitors Compared to JAK1/2-Inhibition in T-ALLJordy C.G. van der Zwet, Jules P.P. Meijerink, Jessica G. C. A. M. Buijs-Gladdines et al.|Blood|2020Cited by 2